Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer (Q77292838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

differentiated thyroid carcinoma

4 December 2019

main subject

1 reference

Paloyan E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Walker RP

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Lawrence AM

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

Surgical oncology clinics of North America

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

665-680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

Regulations and policies on radioiodine 131I therapy in Europe

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Thyroid ultrasonography--a review

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Resectional management of thyroid carcinoma invading the airway

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Late consequences of radioiodine for diagnosis and therapy in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Fractures after thyroidectomy in men: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Percent 131I uptake and post-therapy 131I scans: their role in the management of thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

131I therapy for elevated thyroglobulin levels

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Metastasis to the liver in well-differentiated carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Prevalence of fractures in postmenopausal women with thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930239-4

7 January 2021

10.1016/S1055-3207(18)30239-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735128%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference